Dave Falk

7.7K posts

Dave Falk banner
Dave Falk

Dave Falk

@falk_dave

Owner- Sav-Mor Pharmacies -

Katılım Mart 2012
2K Takip Edilen1.6K Takipçiler
Dave Falk retweetledi
NCPA
NCPA@Commpharmacy·
NCPA is proud to support the Rx ACCESS Act that was introduced by @SenTomCotton and @SenTimKaine to benefit the men and women who serve our country. This bipartisan bill will: Require PBMs to reimburse pharmacies participating in Tricare the actual cost of the drug or the NADAC. Ensure pharmacies are paid a dispensing fee equal to the Medicaid dispensing fee. Direct the comptroller general to conduct an annual audit of Tricare PBM data. Full bill text: cotton.senate.gov/imo/media/doc/…
NCPA tweet media
English
0
6
14
394
Dave Falk retweetledi
ATAP
ATAP@ATAPAdvocates·
The proposed law aims to amend the Employee Retirement Income Security Act (ERISA) to prohibit pharmacy benefit managers from paying kickbacks for steering health plan business to them. quiverquant.com/news/Press+Rel…
English
0
5
5
220
Dave Falk retweetledi
Douglas Hoey
Douglas Hoey@RPhDouglas·
TN bill gives CVS a choice: be a pharmacy or be a PBM. Just not both. It's not hard to guess which they'd choose...PBMs are a profit driver..."where your treasure is, your heart will be also"...
NCPA@Commpharmacy

A bill to ban Insurance companies/PBMs from also operating pharmacies in Tennessee is winding its way through the legislature. @TNPharmacists CEO Anthony Pudlo is fighting it out in the trenches. “It’s a little disheartening to see that CVS is choosing their PBM business over their pharmacies,” said @pudlo. Read the full article: bit.ly/3PDKFHM

English
4
17
60
5.2K
Dave Falk
Dave Falk@falk_dave·
@InsOligopoly @wesmoss1018 Need to talk to other suppliers, obtain some better pay terms. Even 30 days would give you a lifeline. Still doesn’t fix the PBM paying problem, but will give you some relief. Be prepared to walk from your current supplier if they don’t accommodate .
English
0
0
3
145
InsuranceOligopoly
InsuranceOligopoly@InsOligopoly·
My PBM Mafia Life The numbers Independent community retail pharmacy with DME, including home oxygen. $2,200,000 purchase loan incl. real estate $12,000 monthly payment ($529,122 balance) Since 2021 $150,000 SBA loan ($120,000 bal) $50,000 line of credit ($50,000 bal) $50,000 second line of credit ($44,000 bal) $50,000 business loan ($32,000 bal) $250,000 business loan awaiting underwriting Store payroll biweekly $16,000 plus $5,000 for taxes and Medicare 3 pharmacist 4 full time certified techs 2 full time DME 2 part time DME 1 part time respiratory therapist 3 part time cashiers (high school students) Owner & Pharmacist in Charge $50/hr, 40 hr week. $2488 home mortgage No other debt! Drug bills: $160,000+ biweekly Purchase 1st-15th, due 25th Purchase 16th-31st, due 10th PBM pays what they want, when they want, audits as much as they want Next billing cycle starts Monday: $50,000 order and a stack of owes. Spend a dollar for drug. Spend $8 to operate business. Get $6.25 from PBM 45 days after dispensing. Without loans be out of business long ago. Without bank loan would still be short paying drug bills. Without at least one payroll would still be short paying drug bills. @MeadorFTC @AFergusonFTC thanks for the oligopoly and vertical integration $0 dispensing fees $0 net profit Patient steering Spread pricing 10-100X what we make Been a pharmacist over 20 years and I contemplate suicide. So sick of the injustice.
InsuranceOligopoly tweet mediaInsuranceOligopoly tweet media
English
11
11
48
3.2K
Dave Falk retweetledi
FixRx
FixRx@FixRxorg·
ZXX
1
20
48
532
Dave Falk retweetledi
Dave Falk retweetledi
InsuranceOligopoly
InsuranceOligopoly@InsOligopoly·
Day 2087 of waiting for fair trade practices between independent community retail pharmacy and vertically integrated oligopolies. Typical week: Fill 1542 prescriptions in 49 hours 173 (11.22%) brands 40/173 (23%) of brands reimbursed below cost. $600.71, net loss, weekly 1333 (86%) billed to insurance 334/1333 (25%) of insurance claims have $0 paid to pharmacy by PBM 351/1333 (26%) of insurance claims PBM pays $0.01 to $5 to pharmacy 4 PBMs control 87% of pharmacy network 86% of our customers expect we bill their PBM network PBM’s offer take it or leave it nonnegotiable contracts with $0, $0.05, $0.25 dispensing fees, while 1 in 4 of claims getting $0 from PBM @cvspharmacy, @Walmart, @ExpressScripts mail order do not dispense prescriptions for $0 dispensing fees and 90 day supplies for below $1. Why are the rules, the reimbursements different for independents! The entities that control the market mandate requirements and credentials and then pay $0 These same entities pay themselves 10-100x more than they pay independents for same product and service @mcuban @elonmusk @AFergusonFTC @WaysMeansCmte @WaysandMeansGOP @kevinmd @DrugChannels @DGlaucomflecken @SenateGOP @SenateDems @OversightDems @GOPoversight @nytimes @WSJ @SecKennedy @NIHDirector_Jay @OIGatHHS @JusticeOIG
InsuranceOligopoly tweet mediaInsuranceOligopoly tweet mediaInsuranceOligopoly tweet mediaInsuranceOligopoly tweet media
English
2
21
48
1.2K
Dave Falk
Dave Falk@falk_dave·
100% @mcuban ! This is not rocket science. Get the middlemen out of this business (other than claims processing)!
Mark Cuban@mcuban

Tell me you are a politician without telling me you are a politician. Want to cut the price of brand medications and specialty drugs ? (Generics are already cheaper here than most other countries. ) Work with brand manufacturers to sell through distributors at their net price. The manufacturers would make the exact some money. Maybe more. The 3 wholesale distributors , ( that control more than 90pct of the market and are working as fast as they can to be vertically integrated) , can add the same margin and float dollars to the net cost of those drugs when they sell to pharmacies, clinics and others. Pharmacies, when they buy from those wholesalers at net price plus, can buy at substantially lower prices than they do now. Saving their cash flow. Allowing them to expand inventories for patients and most importantly, sell to PATIENTS AT THEIR COST PLUS A COMPETITIVE MARGIN This would save patients billions of dollars. Where would the savings come from ? PBMs, the insurance companies that own them, or that they own, and employers that keep their rebates. One single step makes all of this possible. Some may say the PBM settlements and laws that introduce Point of Sale Rebates to patients will change all of this. It won’t. All the power remains with the PBMs. They negotiate , collect, hold, late pay, and clawback those rebates. What could possibly go wrong ? Unless the legislation requires that brand meds be sold at net, it’s not going to have a major impact. The PBMs/Insurance companies will game the system Fair drug pricing requires legislation, not executive orders thehill.com/opinion/health…

English
0
0
5
460
Dave Falk retweetledi
Pharmacy Podcast Network
Pharmacy Podcast Network@PharmacyPodcast·
Vertical integration in healthcare, like CVS Aetna Caremark, can limit patient choice and inflate prices. Pharmacy Benefit Managers (PBMs) are reportedly overriding doctors and pharmacists for profit. #Healthcare #PatientAdvocacy
English
5
18
31
1.2K
Kyle Busch
Kyle Busch@KyleBusch·
Led lap 3️⃣ for Dale plus a few more today. Made it to the end, just not in the right spot. Thx to #RowdyNation for the endless messages and support. @RCRracing brought a fast @ZonePouches 🎱 all week. Should have another 🚀 at ATL.
Kyle Busch tweet mediaKyle Busch tweet mediaKyle Busch tweet media
English
123
204
4.2K
53K
Dave Falk retweetledi
NCPA
NCPA@Commpharmacy·
🍿 Today at around 10:15 a.m. ET, the @HouseCommerce / @EnergyCommerce Subcommittee on Health is holding a hearing on the role of the prescription drug supply chain in health care affordability. NCPA CEO @RPhDouglas will be on the panel of witnesses at the hearing. ⬇️ To tune in and get more information, including Douglas' written testimony, visit the committee's website. bit.ly/3OiShPj
English
1
8
10
1.1K
Dave Falk
Dave Falk@falk_dave·
This is a nationwide issue…
NACDS@NACDS

📰 "As pharmacy closures accelerate, the cost of inaction becomes increasingly severe. When a pharmacy closes, patients lose access, communities lose a trusted healthcare provider, and small businesses disappear," says Brian Clark, CEO of @yourSCPhA. "South Carolina can protect patient choice and stabilize access to care by advancing meaningful pharmacy benefit manager reform, starting with H.4791 and S.342. Delay is not an option." We couldn’t agree more. PBM practices are driving pharmacy closures, limiting patient choice, and undermining access to care across South Carolina — particularly in rural and underserved communities. Now is the moment for state leaders to act and deliver real PBM reform that protects patients, preserves local pharmacies, and strengthens the healthcare infrastructure communities rely on every day. #PBMReform Check out the full column 👇 postandcourier.com/opinion/commen…

English
2
5
15
1.4K
Dave Falk retweetledi
NCPA
NCPA@Commpharmacy·
"When PBMs reimburse pharmacies below the actual cost of dispensing medications, pharmacies are forced to absorb losses simply to serve their patients," writes Tim Mitchell, owner of Mitchell’s Drug Store in Neosho, Mo. "Over time, this threatens the sustainability of local pharmacies and limits patient access to essential medications and trusted health care services. Patients may face longer travel distances, delays in care, or reduced services — not because pharmacies are failing, but because the system is broken." columbiamissourian.com/opinion/letter… @CoMissourian
English
0
14
40
808
Dave Falk retweetledi
NCPA
NCPA@Commpharmacy·
🤝 Today we're unveiling the NCPA State Panel of Experts, a new program for state pharmacy associations that offers complimentary access to the country's best policy and legal minds to help with advancing pharmacy and patient-friendly policies. “Whether they’re fighting to change the pharmacy payment model and abusive PBM practices, pushing to advance pharmacists’ ability to practice at the top of their license, or serving the interests of their members in any other way, state pharmacy associations across the country do remarkable work, especially considering the limited resources and bandwidth they may have,” said NCPA CEO B. Douglas Hoey in announcing the program. “In addition to our federal and regulatory efforts, NCPA has also historically invested in state efforts to support independent pharmacy. We’re pleased to be adding this more formalized, free tool to support the work of our state colleagues.” Learn more: bit.ly/4t896wk
NCPA tweet media
English
0
6
11
467